JOURNAL ARTICLE
REVIEW
Add like
Add dislike
Add to saved papers

PCL/EUG scaffolds with tunable stiffness can regulate macrophage secretion behavior.

Osteoarthritis (OA) is a prevalent joint disorder worldwide. Recent studies suggested that macrophages play an important role in the progression of OA. However, the detailed pathology related to macrophages is still ambiguous, especially those related to mechanotransduction. In this study, PCL/EUG composite scaffolds were first fabricated by electrospinning. The stiffness of as-fabricated scaffolds was controlled by adjusting the PCL-versus-EUG ratio. The mechanical properties, structural characterics and chemical composition of the scaffolds were investigated using various materials characterization techniques. The results showed that the stiffness of the scaffolds was in the same range as the cartilage tissues with OA. Confocal microscope and RT-PCR were performed to investigate the macrophages cultured on the scaffolds. Significant morphological change of cells was observed. The expression of inflammatory and fibrosis-related cytokines increases as the scaffold stiffness decreases, similar to the trend observed in OA progression.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

Related Resources

For the best experience, use the Read mobile app

Mobile app image

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

By using this service, you agree to our terms of use and privacy policy.

Your Privacy Choices Toggle icon

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app